target directory

acute lymphoblastic leukaemia all treatment with a focus on risk stratification and innovative therapies including inotuzumab ozogamicin and blinatumomab clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.